Konstantin Tachkov

Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

Brian Godman, Holly McCabe, Trudy Leong et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2020 · 86 citations · Full text

Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents

Meri Amerikova, Ivanka Pencheva, Vania Maslarska et al. · Biotechnology & Biotechnological Equipment · 2019 · 83 citations · Full text

New Technologies, Usual Antibiotics, Peptide Engineering +19

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 67 citations · Full text

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

Konstantin Tachkov, Antal Zemplényi, Maria Kamusheva et al. · Frontiers in Public Health · 2022 · 45 citations · Full text

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

Kamila Urbańczyk, Sonja Guntschnig, Vasilis Antoniadis et al. · Frontiers in Pharmacology · 2023 · 42 citations · Full text

Eastern Europe, Effective Use, Patient Selection +20